Secondary Logo

Journal Logo

Most Popular Articles

Heating Injection Drug Preparation Equipment Used for Opioid Injection May Reduce HIV Transmission Associated With Sharing Equipment

Ball, Laura J.; Venner, Colin; Tirona, Rommel G.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 81(4):e127-e134, August 1, 2019.

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

Rizzardini, Giuliano; Overton, Edgar T.; Orkin, Chloe; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 85(4):498-506, December 1, 2020.

Population-Level Effectiveness of HIV Pre-exposure Prophylaxis Among MSM and Transgender Persons With Bacterial Sexually Transmitted Infections

Pagkas-Bather, Jade; Khosropour, Christine M.; Golden, Matthew R.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(2):769-775, June 1, 2021.

Third-Line Antiretroviral Therapy Program in the South African Public Sector: Cohort Description and Virological Outcomes

Moorhouse, Michelle; Maartens, Gary; Venter, Willem Daniel Francois; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 80(1):73-78, January 1, 2019.

Brief Report: Switching to DOR/3TC/TDF Maintains HIV-1 Virologic Suppression Through Week 144 in the DRIVE-SHIFT Trial

Kumar, Princy; Johnson, Margaret; Molina, Jean-Michel; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(2):801-805, June 1, 2021.

Brief Report: Improvement in Metabolic Health Parameters at Week 48 After Switching From a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen to the 2-Drug Regimen of Dolutegravir/Lamivudine: The TANGO Study

van Wyk, Jean; Ait-Khaled, Mounir; Santos, Jesus; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(2):794-800, June 1, 2021.

Estimating the Population Size of Female Sex Workers in Zimbabwe: Comparison of Estimates Obtained Using Different Methods in Twenty Sites and Development of a National-Level Estimate

Fearon, Elizabeth; Chabata, Sungai T.; Magutshwa, Sitholubuhle; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 85(1):30-38, September 1, 2020.

Assessing the Potential Impact of Disruptions Due to COVID-19 on HIV Among Key and Lower-Risk Populations in the Largest Cities of Cameroon and Benin

Silhol, Romain; Geidelberg, Lily; Mitchell, Kate M.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(3):899-911, July 1, 2021.

Characteristics of Black Men Who Have Sex With Men in Baltimore, Philadelphia, and Washington, D.C.: Geographic Diversity in Socio-Demographics and HIV Transmission Risk

German, Danielle; Brady, Kathleen; Kuo, Irene; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 75:S296-S308, July 1, 2017.

Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial

Johnson, Margaret; Kumar, Princy; Molina, Jean-Michel; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 81(4):463-472, August 1, 2019.

How Can Programs Better Support Female Sex Workers to Avoid HIV Infection in Zimbabwe? A Prevention Cascade Analysis

Fearon, Elizabeth; Phillips, Andrew; Mtetwa, Sibongile; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 81(1):24-35, May 1, 2019.

High Prevalence of NRTI and NNRTI Drug Resistance Among ART-Experienced, Hospitalized Inpatients

Bossard, Claire; Schramm, Birgit; Wanjala, Stephen; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(3):883-888, July 1, 2021.

PrEP Use Among Female Sex Workers: No Evidence for Risk Compensation

Giguère, Katia; Béhanzin, Luc; Guédou, Fernand A.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 82(3):257-264, November 1, 2019.

Feasibility and Accuracy of HIV Testing of Children by Caregivers Using Oral Mucosal Transudate HIV Tests

Dziva Chikwari, Chido; Simms, Victoria; Kranzer, Katharina; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(2):781-788, June 1, 2021.

Is on-Demand HIV Pre-exposure Prophylaxis a Suitable Tool for Men Who Have Sex With Men Who Practice Chemsex? Results From a Substudy of the ANRS-IPERGAY Trial

Roux, Perrine; Fressard, Lisa; Suzan-Monti, Marie; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 79(2):e69-e75, October 1, 2018.

Performance of a True Point-of-Care Assay for HIV-1/2 Viral Load Measurement at Antenatal and Postpartum Services

Meggi, Bindiya; Bollinger, Timothy; Zitha, Alcina; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(1):693-699, May 1, 2021.

“I Just Decided to Stop:” Understanding PrEP Discontinuation Among Individuals Initiating PrEP in HIV Care Centers in Kenya

Ongolly, Fernandos K.; Dolla, Annabel; Ngure, Kenneth; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(1):e150-e158, May 1, 2021.

Review of Doravirine Resistance Patterns Identified in Participants During Clinical Development

Martin, Elizabeth Anne; Lai, Ming-Tain; Ngo, Winnie; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 85(5):635-642, December 15, 2020.

Comparison of Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Participants Enrolled in a Multinational Clinical Trial: HPTN 052

Greer, Amy E.; Ou, San-San; Wilson, Ethan; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 76(4):388-393, December 1, 2017.

Outcomes Among HIV-Positive Patients Hospitalized With COVID-19

Karmen-Tuohy, Savannah; Carlucci, Philip M.; Zervou, Fainareti N.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 85(1):6-10, September 1, 2020.

The Effect of PrEP on HIV Incidence Among Men Who Have Sex With Men in the Context of Condom Use, Treatment as Prevention, and Seroadaptive Practices

LeVasseur, Michael T.; Goldstein, Neal D.; Tabb, Loni P.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 77(1):31-40, January 1, 2018.

What’s in a Name? A Mixed Method Study on How Young Women Who Sell Sex Characterize Male Partners and Their Use of Condoms

Busza, Joanna; Hensen, Bernadette; Birdthistle, Isolde; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(1):652-662, May 1, 2021.

Use of HIV Pre-exposure Prophylaxis (PrEP) Associated With Lower HIV Anxiety Among Gay and Bisexual Men in Australia Who Are at High Risk of HIV Infection: Results From the Flux Study

Keen, Phillip; Hammoud, Mohamed A.; Bourne, Adam; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 83(2):119-125, February 1, 2020.

Antiviral Activity, Safety, and Pharmacokinetics/Pharmacodynamics of Tenofovir Alafenamide as 10-Day Monotherapy in HIV-1–Positive Adults

Ruane, Peter J.; DeJesus, Edwin; Berger, Daniel; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(4):449-455, August 1, 2013.

The Shang Ring Device for Adult Male Circumcision: A Proof of Concept Study in Kenya

Barone, Mark A; Ndede, Frederick; Li, Philip S; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 57(1):e7-e12, May 1, 2011.

Antiretroviral Adherence Level Necessary for HIV Viral Suppression Using Real-World Data

Byrd, Kathy K.; Hou, John G.; Hazen, Ron; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 82(3):245-251, November 1, 2019.

Brief Report: Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF), Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results

Arribas, José R.; Thompson, Melanie; Sax, Paul E.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 75(2):211-218, June 1, 2017.

Brief Report: Recent HIV Infection Surveillance in Routine HIV Testing in Nairobi, Kenya: A Feasibility Study

Welty, Susie; Motoku, John; Muriithi, Chris; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 84(1):5-9, May 1, 2020.

A Systematic Review of the Inclusion (or Exclusion) of Women in HIV Research: From Clinical Studies of Antiretrovirals and Vaccines to Cure Strategies

Curno, Mirjam J.; Rossi, Samuela; Hodges-Mameletzis, Ioannis; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 71(2):181-188, February 1, 2016.

Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment–Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials

Cahn, Pedro; Madero, Juan Sierra; Arribas, José R.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 83(3):310-318, March 1, 2020.

HIV-Related Implementation Research for Key Populations: Designing for Individuals, Evaluating Across Populations, and Integrating Context

Schwartz, Sheree R.; Rao, Amrita; Rucinski, Katherine B.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 82:S206-S216, December 2019.

  • CME Quiz

Brief Report: HIV Antibodies Decline During Antiretroviral Therapy but Remain Correlated With HIV DNA and HIV-Specific T-Cell Responses

Keating, Sheila M.; Jones, Richard Brad; Lalama, Christina M.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 81(5):594-599, August 15, 2019.

Updates of Lifetime Costs of Care and Quality-of-Life Estimates for HIV-Infected Persons in the United States: Late Versus Early Diagnosis and Entry Into Care

Farnham, Paul G.; Gopalappa, Chaitra; Sansom, Stephanie L.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 64(2):183-189, October 1, 2013.

Reduction of Injection-Related Risk Behaviors After Emergency Implementation of a Syringe Services Program During an HIV Outbreak

Patel, Monita R.; Foote, Carrie; Duwve, Joan; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 77(4):373-382, April 1, 2018.

Brief Report: Weight Gain Following ART Initiation in ART-Naïve People Living With HIV in the Current Treatment Era

Ruderman, Stephanie A.; Crane, Heidi M.; Nance, Robin M.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 86(3):339-343, March 1, 2021.

The Development of PROQOL-HIV: An International Instrument to Assess the Health-Related Quality of Life of Persons Living With HIV/AIDS

Duracinsky, Martin; Herrmann, Susan; Berzins, Baiba; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 59(5):498-505, April 15, 2012.

Outcomes of Three- Versus Six-Monthly Dispensing of Antiretroviral Treatment (ART) for Stable HIV Patients in Community ART Refill Groups: A Cluster-Randomized Trial in Zimbabwe

Fatti, Geoffrey; Ngorima-Mabhena, Nicoletta; Mothibi, Eula; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 84(2):162-172, June 1, 2020.

Tenofovir, Emtricitabine Intracellular and Plasma, and Efavirenz Plasma Concentration Decay Following Drug Intake Cessation: Implications for HIV Treatment and Prevention

Jackson, Akil; Moyle, Graeme; Watson, Victoria; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 62(3):275-281, March 1, 2013.

Should Urine-LAM Tests Be Used in TB Symptomatic HIV-Positive Patients When No CD4 Count Is Available? A Prospective Observational Cohort Study From Malawi

Huerga, Helena; Rucker, Sekai Chenai Mathabire; Bastard, Mathieu; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 83(1):24-30, January 1, 2020.

Efficacy and Safety of Atazanavir, With or Without Ritonavir, as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive Patients

(Niel) Malan, D. R; Krantz, Edrich; David, Neal; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):161-167, February 1, 2008.

Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Dolutegravir (DTG)+F/TAF or DTG+F/Tenofovir Disoproxil Fumarate (TDF) in the Presence of Pre-existing NRTI Resistance

Acosta, Rima K.; Willkom, Madeleine; Andreatta, Kristen; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 85(3):363-371, November 01, 2020.

Human-Centered Design Lessons for Implementation Science: Improving the Implementation of a Patient-Centered Care Intervention

Beres, Laura K.; Simbeza, Sandra; Holmes, Charles B.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 82:S230-S243, December 2019.

Brief Report: Virologic Response by Baseline Viral Load With Dolutegravir Plus Lamivudine vs Dolutegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Analysis

Eron, Joseph; Hung, Chien-Ching; Baril, Jean-Guy; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 84(1):60-65, May 1, 2020.

Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial

Kityo, Cissy; Hagins, Debbie; Koenig, Ellen; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 82(3):321-328, November 1, 2019.

Brief Report: Switching From TDF to TAF in HIV/HBV-Coinfected Individuals With Renal Dysfunction—A Prospective Cohort Study

Surial, Bernard; Béguelin, Charles; Chave, Jean-Philippe; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 85(2):227-232, October 1, 2020.

Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients: Final 5-Year Results From STARTMRK

Rockstroh, Jürgen K.; DeJesus, Edwin; Lennox, Jeffrey L.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(1):77-85, May 1, 2013.

Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical Trial

Flynn, Patricia M.; Taha, Taha E.; Cababasay, Mae; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 77(4):383-392, April 1, 2018.

Drivers of HIV Infection Among Cisgender and Transgender Female Sex Worker Populations in Baltimore City: Results From the SAPPHIRE Study

Sherman, Susan G.; Park, Ju Nyeong; Galai, Noya; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 80(5):513-521, April 15, 2019.

Mortality in the Highly Active Antiretroviral Therapy Era: Changing Causes of Death and Disease in the HIV Outpatient Study

Palella, Frank J. Jr; Baker, Rose K.; Moorman, Anne C.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 43(1):27-34, September 2006.

The Economic Burden of HIV in the United States in the Era of Highly Active Antiretroviral Therapy: Evidence of Continuing Racial and Ethnic Differences

Hutchinson, Angela B; Farnham, Paul G; Dean, Hazel D; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 43(4):451-457, December 1, 2006.

Venue-Based HIV Testing at Sex Work Hotspots to Reach Adolescent Girls and Young Women Living With HIV: A Cross-sectional Study in Mombasa, Kenya

Ma, Huiting; Wang, Linwei; Gichangi, Peter; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 84(5):470-479, August 15, 2020.

A Global Research Agenda for Adolescents Living With HIV

Armstrong, Alice; Nagata, Jason M.; Vicari, Marissa; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 78:S16-S21, August 15, 2018.

Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Disorder

Molinaro, Maria; Sacktor, Ned; Nakigozi, Gertrude; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 83(3):278-283, March 1, 2020.

Pharmacokinetics, Safety, and Tolerability With Repeat Doses of GSK1265744 and Rilpivirine (TMC278) Long-Acting Nanosuspensions in Healthy Adults

Spreen, William; Williams, Peter; Margolis, David; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(5):487-492, December 15, 2014.

Show: